NY-ESO-1 Cancer Testis Antigen Demonstrates High Immunogenicity in Triple Negative Breast Cancer
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
NY-ESO-1 Cancer Testis Antigen Demonstrates High Immunogenicity in Triple Negative Breast Cancer
Authors
Keywords
-
Journal
PLoS One
Volume 7, Issue 6, Pages e38783
Publisher
Public Library of Science (PLoS)
Online
2012-06-29
DOI
10.1371/journal.pone.0038783
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Immunoediting and persistence of antigen-specific immunity in patients who have previously been vaccinated with NY-ESO-1 protein formulated in ISCOMATRIX™
- (2011) Theo Nicholaou et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- A phase I study of vaccination with NY-ESO-1f peptide mixed with Picibanil OK-432 and Montanide ISA-51 in patients with cancers expressing the NY-ESO-1 antigen
- (2011) Kazuhiro Kakimi et al. INTERNATIONAL JOURNAL OF CANCER
- Tumor-Infiltrating CD8+ Lymphocytes Predict Clinical Outcome in Breast Cancer
- (2011) Sahar M.A. Mahmoud et al. JOURNAL OF CLINICAL ONCOLOGY
- Increased Levels of Tumor-Infiltrating Lymphocytes are Associated with Improved Recurrence-Free Survival in Stage 1A Non-Small-Cell Lung Cancer
- (2011) Zachary D. Horne et al. JOURNAL OF SURGICAL RESEARCH
- Multiple Cancer/Testis Antigens Are Preferentially Expressed in Hormone-Receptor Negative and High-Grade Breast Cancers
- (2011) Yao-Tseng Chen et al. PLoS One
- Antibody Responses to NY-ESO-1 in Primary Breast Cancer Identify a Subtype Target for Immunotherapy
- (2011) Ahmed Hamaï et al. PLoS One
- Integrated NY-ESO-1 antibody and CD8+ T-cell responses correlate with clinical benefit in advanced melanoma patients treated with ipilimumab
- (2011) J. Yuan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cancer-testis antigen expression in triple-negative breast cancer
- (2010) G. Curigliano et al. ANNALS OF ONCOLOGY
- A phase 1 and pharmacodynamic study of decitabine in combination with carboplatin in patients with recurrent, platinum-resistant, epithelial ovarian cancer
- (2010) Fang Fang et al. CANCER
- Tumour-infiltrating T-cell subsets, molecular changes in colorectal cancer, and prognosis: cohort study and literature review
- (2010) Katsuhiko Nosho et al. JOURNAL OF PATHOLOGY
- Seromic profiling of ovarian and pancreatic cancer
- (2010) S. Gnjatic et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- NY-ESO-1 DNA Vaccine Induces T-Cell Responses That Are Suppressed by Regulatory T Cells
- (2009) S. Gnjatic et al. CLINICAL CANCER RESEARCH
- CT-X antigen expression in human breast cancer
- (2009) A. Grigoriadis et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Intertumor and Intratumor NY-ESO-1 Expression Heterogeneity Is Associated with Promoter-Specific and Global DNA Methylation Status in Ovarian Cancer
- (2008) A. Woloszynska-Read et al. CLINICAL CANCER RESEARCH
- CTdatabase: a knowledge-base of high-throughput and curated data on cancer-testis antigens
- (2008) L. G. Almeida et al. NUCLEIC ACIDS RESEARCH
- Genome-wide analysis of cancer/testis gene expression
- (2008) O. Hofmann et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started